Guardian Pharmacy Services Inc reports results for the quarter ended June 30 - Earnings Summary

Guardian Pharmacy Services

11/08/2025 22:02

Guardian Pharmacy Services Inc GRDN.N reported quarterly adjusted earnings of 14 cents​​ per share for the quarter ended June 30.  The mean expectation of three analysts for the quarter was for earnings of 16 cents per share. Wall Street expected results to range from 15 cents to 16 cents per share.

Revenue was $344.33 million​; analysts expected $329.82 million.

Guardian Pharmacy Services Inc's reported EPS for the quarter was 14 cents​.

The company reported quarterly net income of $9.03 million.

Guardian Pharmacy Services Inc shares had fallen by 6.3% this quarter and lost 1.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 18.4% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the drug retailers peer group is also "buy"

Wall Street's median 12-month price target for Guardian Pharmacy Services Inc is $28.00, about 29% above its last closing price of $19.88

This summary was machine generated from LSEG data August 11 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
0.16
0.14
Missed
Mar. 31 2025
0.18
0.15
Missed
Dec. 31 2024
0.17
0.19
Beat
Sep. 30 2024
0.19
-2.00
Missed